MIS MiLIF Versus Open

NCT ID: NCT00792129

Last Updated: 2012-02-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

113 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-04-30

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being undertaken to compare the clinical outcomes of patients that have unilateral posterolateral lumbar interbody fusion using a traditional open approach versus the MiLIF procedure based on the MiCOR Precision Bone Allograft, specialized Atavi instrumentation, and minimally invasive visualization capabilities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multi-center, non-randomized cohort design clinical study to evaluate the clinical outcomes of patients that have a minimally invasive lumbar interbody fusion (MiLIF) through the Atavi system compared to traditional unilateral open lumbar interbody fusion through a midline incision. the study will involve up to approximately 12 investigational sites and enroll up to 126 patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Low Back Pain Leg Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Posterior unilateral interbody fusion using an open approach midline incision (TLIF)

The Atavi System

Intervention Type DEVICE

The primary device in the Atavi system is the Flex Posture retractor and accessories such as dilators and an Expander Instrument.

The Atavi System includes instruments used to access the spine by dilation of the overlying tissues, as well as a retracting device that is used to maintain the access. Once the retractor is in place, the visualization components of the system may be used.

Experimental

MiLIF procedure with specialized Atavi instrumentation and minimally invasive visualization capabilities

The Atavi System

Intervention Type DEVICE

The primary device in the Atavi system is the Flex Posture retractor and accessories such as dilators and an Expander Instrument.

The Atavi System includes instruments used to access the spine by dilation of the overlying tissues, as well as a retracting device that is used to maintain the access. Once the retractor is in place, the visualization components of the system may be used.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The Atavi System

The primary device in the Atavi system is the Flex Posture retractor and accessories such as dilators and an Expander Instrument.

The Atavi System includes instruments used to access the spine by dilation of the overlying tissues, as well as a retracting device that is used to maintain the access. Once the retractor is in place, the visualization components of the system may be used.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MIS Minimally invasive Atavi Flex Posure retractor

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is between 18 and 75 years of age
* Patient is scheduled for an elective spinal lumbar interbody single level fusion
* Patient is a candidate for posterior unilateral lumbar fusion through a midline incision
* Indication for surgery and dominant symptom of chronic low back and/or leg pain
* Diagnosis of one or more of the following:

* Primary symptomatic degenerative disc disease confirmed with appropriate imaging studies and/or positive lumbar discography
* Spondylolisthesis Grade I/II
* The affected motion segment reside in L2-S1 and are adjacent segments
* Patient, or authorized representative, signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure.

Exclusion Criteria

* Patient has a known fracture in the lumbar spine
* Patient has systemic infection or evidence of any surgical site infection (superficial or organ space)
* Patient has compromised immune system or autoimmune disease (WBC\<4000 or \>20,000)
* Patient has uncontrolled diabetes
* Patient has a known malignancy
* Prior lumbar fusion attempt; prior laminectomy and/or discectomy are allowed
* Known medical or anatomical condition that would preclude a posterior lumbar fusion using metallic instrumentation (e.g., severe osteopenia)
* Patient with a planned placement of an electric bone stimulator
* Patient with a planned placement of indwelling epidural catheter for a long term pain management
* Patient is pregnant or wishes to become pregnant during the length of the study participation
* Patient is currently in litigation
* Patient is not likely to comply with the follow-up evaluation schedule
* Patient is participating in a clinical trial of another investigational drug or device.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joe Murar, M.D.

Role: STUDY_DIRECTOR

Zimmer Spine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

La Jolla Spine Institute

La Jolla, California, United States

Site Status

Sharp Rees-Stealy Medical Group

San Diego, California, United States

Site Status

Advanced Orthopedic Center

Port Charlotte, Florida, United States

Site Status

Southeastern Spine Center

Sarasota, Florida, United States

Site Status

Kennedy-White Orthopedic

Sarasota, Florida, United States

Site Status

Oregon Brain & Spinal Institute

Portland, Oregon, United States

Site Status

Williamette Neurosurgery

Salem, Oregon, United States

Site Status

William Beaumont Army Medical Center

El Paso, Texas, United States

Site Status

Naval Medical Center

Portsmouth, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2007-003

Identifier Type: -

Identifier Source: secondary_id

ATV-03-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transforaminal Lumbar Interbody Fusion (TLIF)
NCT04073563 ACTIVE_NOT_RECRUITING NA
OLIF25™ /OLIF51™ Study
NCT02657421 TERMINATED
Lumbar Fusion With Porous Versus Non-Porous Cages
NCT05583864 ACTIVE_NOT_RECRUITING NA
CONDUIT vs. PEEK Cages
NCT06904898 ENROLLING_BY_INVITATION NA